Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0658
D

Improper Insulin Administration Due to Supply Shortage

Martin, Tennessee Survey Completed on 04-03-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to adhere to professional standards of quality in medication administration when a Licensed Practical Nurse (LPN) used improper supplies to administer insulin. According to the facility's Clinical Skills Fair Guide, the correct procedure for using a FlexPen, a pre-filled insulin delivery device, involves attaching a new needle to the pen, dialing the required units, and injecting the insulin directly. However, during an observation, LPN A was seen drawing insulin from the FlexPen into an insulin syringe instead of using the pen as intended. LPN A explained that the facility had run out of FlexPen needles a few days prior, and this method was previously suggested in January. The Director of Nursing (DON) was unaware of the shortage of FlexPen needles and the alternative method being used by the staff. During an interview, the DON mentioned that the pharmacy had previously indicated that using an insulin syringe was acceptable, although she could not recall who provided this information. However, a subsequent interview with the pharmacist revealed that none of the pharmacists remembered any conversation about drawing insulin from the FlexPen with an insulin syringe, indicating a communication breakdown and lack of proper oversight in medication administration procedures.

An unhandled error has occurred. Reload 🗙